Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01398904 · ClinicalTrials.gov registry record
Attentional Bias in Body Dysmorphic Disorder
A clinical trial, sponsored by Massachusetts General Hospital.
- Completed
- Registry status
- 51
- Enrollment target
NCT01398904: Completed study, sponsored by Massachusetts General Hospital.
NCT01398904 is a clinical trial that has completed, run by Massachusetts General Hospital. The registered enrollment target is 51 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT01398904 has completed, sponsored by Massachusetts General Hospital.
- COMPLETED
- Registry status
- 51 participants
- Enrollment target
Study Summary
Body Dysmorphic Disorder (BDD) participants will demonstrate greater attentional biases as compared to healthy control (HC) participants. Greater attention bias will be associated with greater distress. Greater attention bias will be associated with greater symptom severity.
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 51 participants |
| Start Date | 2011-03 |
| Est. Completion | 2012-07 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01398904
The ClinicalTrials.gov registry entry for NCT01398904 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 51 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Massachusetts General Hospital, which has 2,032 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 0 interventions.
NCT01398904 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT01398904 about?
NCT01398904 is a clinical study titled "Attentional Bias in Body Dysmorphic Disorder". Body Dysmorphic Disorder (BDD) participants will demonstrate greater attentional biases as compared to healthy control (HC) participants. Greater attention bias will be associated with greater distress. Greater attention bias will be associated with greater symptom severity.
What is the current status of trial NCT01398904?
This trial is currently completed. The enrollment target is 51 participants. The study started on 2011-03. Estimated completion is 2012-07.
Who is sponsoring clinical trial NCT01398904?
This trial is sponsored by Massachusetts General Hospital, which has 2,032 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.